Abstract
The antidiabetics tolbutamide, glibenclamide, and glipizide, and the diuretics bendroflumethiazide, butizide, furosemide, hydrochlorothiazide, and trichlormethiazide were investigated for potential phototoxicity in the HaCaT cell line. The cells were incubated with the drugs and then exposed to UVA1 irradiation. The effects of the antioxidants L-ascorbic acid, and α-tocopherol on oxidative DNA damage were assessed. Bendroflumethiazide, furosemide, hydrochlorothiazide, trichlormethiazide, or tolbutamide induced dose-dependent phototoxicity. Cells incubated with bendroflumethiazide, tolbutamide, and glibenclamide, and irradiated with UVA1 demonstrated an increased oxidative DNA damage. Pre-treatment with L-ascorbic acid, or α-tocopherol, suppressed the UVA-induced DNA damage in cells incubated with 1 mM of bendroflumethiazide, furosemide, glibenclamide, glipizide, tolbutamide, and trichloromethiazide, further implying the involvement of reactive oxygen species in the phototoxic DNA damage. These results may indicate a link between phototoxic and photocancerogenic potential of the sulfonamide-derived oral antidiabetic and diuretic drugs, as it has previously been recognized for psoralen, chlorpromazine, and fluoroquinolones. Excessive exposure to UV light may be deleterious for patients treated with these drugs.
© 2001 OSA/SPIE
PDF ArticleMore Like This
N.W. Nkune and H. Abrahamse
126270U European Conference on Biomedical Optics (ECBO) 2023
Tiina I. Karu, Natalya I. Afanasyeva, Sergei.V. Kolyakov, Ludmila V. Pyatibrat, and Leslie Weiser
4431_306 European Conference on Biomedical Optics (ECBO) 2001
Juris Rodins, Vadims Korhovs, Talivaldis Freivalds, Indulis Buikis, and Tatjana Ivanova
4432_242 European Conference on Biomedical Optics (ECBO) 2001